Corrigendum to "Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I" [Bioorg. Med. Chem. Lett. 17 (2007) 2639-2642] (DOI:10.1016/j.bmcl.2007.01.097);Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 9, 2007, Pages 2639-2642

  Epifano, Francesco ^a   Curini, Massimo ^b   Genovese, Salvatore ^b   Blaskovich, Michelle ^c   Hamilton, Andrew ^c,d   Sebti, Said M ^c  

^a Dipartimento di Scienze del Farmaco   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Anticancer activity; Cinnamic acid derivatives; Coumarins; Prenyloxyphenylpropanoids; Prenyltransferase

Indexed keywords

CINNAMIC ACID DERIVATIVE; COUMARIN DERIVATIVE; GERANYLGERANYL TRANSFERASE I; GERANYLTRANSFERASE; PRENYLOXYPHENYLPROPANOID DERIVATIVE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG SCREENING; DRUG SELECTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; STRUCTURE ACTIVITY RELATION;

EID: 34047218844     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.07.042     Document Type: Erratum

References (19)

1. Sebti S.M., and Hamilton A.D. Oncogene 19 (2000) 6584
2. Russo P., Loprevite M., Cesario A., and Ardizzoni A. Curr. Med. Chem. Anticancer Agents 4 (2004) 123
3. Pais J.E., Bowers K.E., Stoddard A.K., and Fierke C.A. Anal. Biochem. 345 (2005) 302
4. Appels N.M., Beijinen J.H., and Schellens J.H. Oncologist 10 (2005) 565
5. Basso A.D., Kirschmeier P., and Bishop W.R. J. Lipid Res. 47 (2006) 15
6. El Oualid F., Cohen L.H., Van der Marel G.A., and Overhand M. Curr. Med. Chem. 13 (2006) 2385
7. Curini M., Epifano F., Maltese F., Marcotullio M.C., Tubaro A., Altinier G., Prieto Gonzales S., and Rodriguez J.C. Bioorg. Med. Chem. Lett. 14 (2004) 2241 and references cited herein
8. Curini M., Cravotto G., Epifano F., and Giannone G. Curr. Med. Chem. 1 (2006) 199 and references cited herein
9. Curini M., Epifano F., and Genovese S. Bioorg. Med. Chem. Lett. 15 (2005) 5049
10. Kohno H., Suzuki R., Curini M., Epifano F., Maltese F., Prieto Gonzales S., and Tanaka T. Int. J. Cancer 118 (2006) 2936
11. Epifano F., Menghini L., Pagiotti R., Angelini P., Genovese S., and Curini M. Bioorg. Med. Chem. Lett. 16 (2006) 5523
12. Prager R.H., and Thregold H.M. Aust. J. Chem. 19 (1966) 451
13. Curini M., Epifano F., Genovese S., Marcotullio M.C., and Menghini L. Anticancer Agents Med. Chem. 6 (2006) 571
14. Ito C., Itoigawa M., Otsuka T., Tokuda H., Nishino H., and Furukawa H. J. Nat. Prod 63 (2000) 1344
15. Ali M.S., and Pervez M.K. Nat. Prod. Res 18 (2004) 141
16. Perry N.B., Foster L.M., Lorimer S.D., May B.C., and Weavers R.T. J. Nat. Prod. 59 (1996) 729
17. 8 Prenyltransferase activity assays.
18. Hosoda A., Miyake Y., Nomura E., Mizuno K., and Taniguchi H. ITE Lett. 2 (2001) 659
19. Vogt A., Qian Y., McGuire T.F., Hamilton A.D., and Sebti S.M. Oncogene 13 (1996) 1991